 | • レポートコード：GIR-2104Z09036 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、134ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥494,160 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥741,240 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥988,320 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、変形性関節症（OA）疼痛薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。変形性関節症（OA）疼痛薬の種類別市場規模（経口、注射、外部）、用途別市場規模（医療、パーソナルケア）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・変形性関節症（OA）疼痛薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Pfizer、Johnson and Johnson、GlaxoSmithKline、Bayer、Eli Lilly、Novartis、Sanofi、Horizon Pharma、Abbott、Mylan、Daiichi Sankyo、TEVA、Almatica Pharma、Astellas Pharma、Tide Pharmaceutical、Iroko Pharmaceuticals、Hengrui Pharmaceutical、Abiogen Pharma ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：経口、注射、外部 ・用途別分析2016年-2026年：医療、パーソナルケア ・変形性関節症（OA）疼痛薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・変形性関節症（OA）疼痛薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・変形性関節症（OA）疼痛薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・変形性関節症（OA）疼痛薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・変形性関節症（OA）疼痛薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Medicine for Osteoarthritis Pain market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Medicine for Osteoarthritis Pain size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Medicine for Osteoarthritis Pain market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Medicine for Osteoarthritis Pain market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Oral
Injection
External
Market segment by Application can be divided into
Medical Care
Personal Care
The key market players for global Medicine for Osteoarthritis Pain market are listed below:
Pfizer
Johnson and Johnson
GlaxoSmithKline
Bayer
Eli Lilly
Novartis
Sanofi
Horizon Pharma
Abbott
Mylan
Daiichi Sankyo
TEVA
Almatica Pharma
Astellas Pharma
Tide Pharmaceutical
Iroko Pharmaceuticals
Hengrui Pharmaceutical
Abiogen Pharma
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Medicine for Osteoarthritis Pain Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Medicine for Osteoarthritis Pain Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Oral
1.2.3 Injection
1.2.4 External
1.3 Market Analysis by Application
1.3.1 Overview: Global Medicine for Osteoarthritis Pain Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Medical Care
1.3.3 Personal Care
1.4 Global Medicine for Osteoarthritis Pain Market Size & Forecast
1.4.1 Global Medicine for Osteoarthritis Pain Sales in Value (2016-2026))
1.4.2 Global Medicine for Osteoarthritis Pain Sales in Volume (2016-2026)
1.4.3 Global Medicine for Osteoarthritis Pain Price by Type (2016-2026) & (USD/Unit)
1.5 Global Medicine for Osteoarthritis Pain Production Capacity Analysis
1.5.1 Global Medicine for Osteoarthritis Pain Total Production Capacity (2016-2026)
1.5.2 Global Medicine for Osteoarthritis Pain Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Medicine for Osteoarthritis Pain Market Drivers
1.6.2 Medicine for Osteoarthritis Pain Market Restraints
1.6.3 Medicine for Osteoarthritis Pain Trends Analysis
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Medicine for Osteoarthritis Pain Product and Services
2.1.4 Pfizer Medicine for Osteoarthritis Pain Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Johnson and Johnson
2.2.1 Johnson and Johnson Details
2.2.2 Johnson and Johnson Major Business
2.2.3 Johnson and Johnson Medicine for Osteoarthritis Pain Product and Services
2.2.4 Johnson and Johnson Medicine for Osteoarthritis Pain Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 GlaxoSmithKline
2.3.1 GlaxoSmithKline Details
2.3.2 GlaxoSmithKline Major Business
2.3.3 GlaxoSmithKline Medicine for Osteoarthritis Pain Product and Services
2.3.4 GlaxoSmithKline Medicine for Osteoarthritis Pain Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Bayer
2.4.1 Bayer Details
2.4.2 Bayer Major Business
2.4.3 Bayer Medicine for Osteoarthritis Pain Product and Services
2.4.4 Bayer Medicine for Osteoarthritis Pain Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Eli Lilly
2.5.1 Eli Lilly Details
2.5.2 Eli Lilly Major Business
2.5.3 Eli Lilly Medicine for Osteoarthritis Pain Product and Services
2.5.4 Eli Lilly Medicine for Osteoarthritis Pain Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Novartis
2.6.1 Novartis Details
2.6.2 Novartis Major Business
2.6.3 Novartis Medicine for Osteoarthritis Pain Product and Services
2.6.4 Novartis Medicine for Osteoarthritis Pain Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Sanofi
2.7.1 Sanofi Details
2.7.2 Sanofi Major Business
2.7.3 Sanofi Medicine for Osteoarthritis Pain Product and Services
2.7.4 Sanofi Medicine for Osteoarthritis Pain Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Horizon Pharma
2.8.1 Horizon Pharma Details
2.8.2 Horizon Pharma Major Business
2.8.3 Horizon Pharma Medicine for Osteoarthritis Pain Product and Services
2.8.4 Horizon Pharma Medicine for Osteoarthritis Pain Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Abbott
2.9.1 Abbott Details
2.9.2 Abbott Major Business
2.9.3 Abbott Medicine for Osteoarthritis Pain Product and Services
2.9.4 Abbott Medicine for Osteoarthritis Pain Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Mylan
2.10.1 Mylan Details
2.10.2 Mylan Major Business
2.10.3 Mylan Medicine for Osteoarthritis Pain Product and Services
2.10.4 Mylan Medicine for Osteoarthritis Pain Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Daiichi Sankyo
2.11.1 Daiichi Sankyo Details
2.11.2 Daiichi Sankyo Major Business
2.11.3 Daiichi Sankyo Medicine for Osteoarthritis Pain Product and Services
2.11.4 Daiichi Sankyo Medicine for Osteoarthritis Pain Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.12 TEVA
2.12.1 TEVA Details
2.12.2 TEVA Major Business
2.12.3 TEVA Medicine for Osteoarthritis Pain Product and Services
2.12.4 TEVA Medicine for Osteoarthritis Pain Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.13 Almatica Pharma
2.13.1 Almatica Pharma Details
2.13.2 Almatica Pharma Major Business
2.13.3 Almatica Pharma Medicine for Osteoarthritis Pain Product and Services
2.13.4 Almatica Pharma Medicine for Osteoarthritis Pain Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.14 Astellas Pharma
2.14.1 Astellas Pharma Details
2.14.2 Astellas Pharma Major Business
2.14.3 Astellas Pharma Medicine for Osteoarthritis Pain Product and Services
2.14.4 Astellas Pharma Medicine for Osteoarthritis Pain Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.15 Tide Pharmaceutical
2.15.1 Tide Pharmaceutical Details
2.15.2 Tide Pharmaceutical Major Business
2.15.3 Tide Pharmaceutical Medicine for Osteoarthritis Pain Product and Services
2.15.4 Tide Pharmaceutical Medicine for Osteoarthritis Pain Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.16 Iroko Pharmaceuticals
2.16.1 Iroko Pharmaceuticals Details
2.16.2 Iroko Pharmaceuticals Major Business
2.16.3 Iroko Pharmaceuticals Medicine for Osteoarthritis Pain Product and Services
2.16.4 Iroko Pharmaceuticals Medicine for Osteoarthritis Pain Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.17 Hengrui Pharmaceutical
2.17.1 Hengrui Pharmaceutical Details
2.17.2 Hengrui Pharmaceutical Major Business
2.17.3 Hengrui Pharmaceutical Medicine for Osteoarthritis Pain Product and Services
2.17.4 Hengrui Pharmaceutical Medicine for Osteoarthritis Pain Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.18 Abiogen Pharma
2.18.1 Abiogen Pharma Details
2.18.2 Abiogen Pharma Major Business
2.18.3 Abiogen Pharma Medicine for Osteoarthritis Pain Product and Services
2.18.4 Abiogen Pharma Medicine for Osteoarthritis Pain Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Medicine for Osteoarthritis Pain Sales by Manufacturer
3.1 Global Medicine for Osteoarthritis Pain Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Medicine for Osteoarthritis Pain Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Medicine for Osteoarthritis Pain
3.4 Market Concentration Rate
3.4.1 Top 3 Medicine for Osteoarthritis Pain Manufacturer Market Share
3.4.2 Top 6 Medicine for Osteoarthritis Pain Manufacturer Market Share
3.5 Global Medicine for Osteoarthritis Pain Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Medicine for Osteoarthritis Pain Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Medicine for Osteoarthritis Pain Market Size by Region
4.1.1 Global Medicine for Osteoarthritis Pain Sales in Volume by Region (2016-2026)
4.1.2 Global Medicine for Osteoarthritis Pain Revenue by Region (2016-2026)
4.2 North America Medicine for Osteoarthritis Pain Revenue (2016-2026)
4.3 Europe Medicine for Osteoarthritis Pain Revenue (2016-2026)
4.4 Asia-Pacific Medicine for Osteoarthritis Pain Revenue (2016-2026)
4.5 South America Medicine for Osteoarthritis Pain Revenue (2016-2026)
4.6 Middle East and Africa Medicine for Osteoarthritis Pain Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Medicine for Osteoarthritis Pain Sales in Volume by Type (2016-2026)
5.2 Global Medicine for Osteoarthritis Pain Revenue by Type (2016-2026)
5.3 Global Medicine for Osteoarthritis Pain Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Medicine for Osteoarthritis Pain Sales in Volume by Application (2016-2026)
6.2 Global Medicine for Osteoarthritis Pain Revenue by Application (2016-2026)
6.3 Global Medicine for Osteoarthritis Pain Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Medicine for Osteoarthritis Pain Sales by Type (2016-2026)
7.2 North America Medicine for Osteoarthritis Pain Sales by Application (2016-2026)
7.3 North America Medicine for Osteoarthritis Pain Market Size by Country
7.3.1 North America Medicine for Osteoarthritis Pain Sales in Volume by Country (2016-2026)
7.3.2 North America Medicine for Osteoarthritis Pain Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Medicine for Osteoarthritis Pain Sales by Type (2016-2026)
8.2 Europe Medicine for Osteoarthritis Pain Sales by Application (2016-2026)
8.3 Europe Medicine for Osteoarthritis Pain Market Size by Country
8.3.1 Europe Medicine for Osteoarthritis Pain Sales in Volume by Country (2016-2026)
8.3.2 Europe Medicine for Osteoarthritis Pain Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Medicine for Osteoarthritis Pain Sales by Type (2016-2026)
9.2 Asia-Pacific Medicine for Osteoarthritis Pain Sales by Application (2016-2026)
9.3 Asia-Pacific Medicine for Osteoarthritis Pain Market Size by Region
9.3.1 Asia-Pacific Medicine for Osteoarthritis Pain Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Medicine for Osteoarthritis Pain Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Medicine for Osteoarthritis Pain Sales by Type (2016-2026)
10.2 South America Medicine for Osteoarthritis Pain Sales by Application (2016-2026)
10.3 South America Medicine for Osteoarthritis Pain Market Size by Country
10.3.1 South America Medicine for Osteoarthritis Pain Sales in Volume by Country (2016-2026)
10.3.2 South America Medicine for Osteoarthritis Pain Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Medicine for Osteoarthritis Pain Sales by Type (2016-2026)
11.2 Middle East & Africa Medicine for Osteoarthritis Pain Sales by Application (2016-2026)
11.3 Middle East & Africa Medicine for Osteoarthritis Pain Market Size by Country
11.3.1 Middle East & Africa Medicine for Osteoarthritis Pain Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Medicine for Osteoarthritis Pain Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Medicine for Osteoarthritis Pain Typical Distributors
12.3 Medicine for Osteoarthritis Pain Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Medicine for Osteoarthritis Pain Revenue by Type, (USD Million), 2021-2026
Table 2. Global Medicine for Osteoarthritis Pain Revenue by Application, (USD Million), 2021-2026
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Medicine for Osteoarthritis Pain Product and Services
Table 6. Pfizer Medicine for Osteoarthritis Pain Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Johnson and Johnson Basic Information, Manufacturing Base and Competitors
Table 8. Johnson and Johnson Major Business
Table 9. Johnson and Johnson Medicine for Osteoarthritis Pain Product and Services
Table 10. Johnson and Johnson Medicine for Osteoarthritis Pain Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 12. GlaxoSmithKline Major Business
Table 13. GlaxoSmithKline Medicine for Osteoarthritis Pain Product and Services
Table 14. GlaxoSmithKline Medicine for Osteoarthritis Pain Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Bayer Basic Information, Manufacturing Base and Competitors
Table 16. Bayer Major Business
Table 17. Bayer Medicine for Osteoarthritis Pain Product and Services
Table 18. Bayer Medicine for Osteoarthritis Pain Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 20. Eli Lilly Major Business
Table 21. Eli Lilly Medicine for Osteoarthritis Pain Product and Services
Table 22. Eli Lilly Medicine for Osteoarthritis Pain Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Novartis Basic Information, Manufacturing Base and Competitors
Table 24. Novartis Major Business
Table 25. Novartis Medicine for Osteoarthritis Pain Product and Services
Table 26. Novartis Medicine for Osteoarthritis Pain Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Sanofi Basic Information, Manufacturing Base and Competitors
Table 28. Sanofi Major Business
Table 29. Sanofi Medicine for Osteoarthritis Pain Product and Services
Table 30. Sanofi Medicine for Osteoarthritis Pain Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Horizon Pharma Basic Information, Manufacturing Base and Competitors
Table 32. Horizon Pharma Major Business
Table 33. Horizon Pharma Medicine for Osteoarthritis Pain Product and Services
Table 34. Horizon Pharma Medicine for Osteoarthritis Pain Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Abbott Basic Information, Manufacturing Base and Competitors
Table 36. Abbott Major Business
Table 37. Abbott Medicine for Osteoarthritis Pain Product and Services
Table 38. Abbott Medicine for Osteoarthritis Pain Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Mylan Basic Information, Manufacturing Base and Competitors
Table 40. Mylan Major Business
Table 41. Mylan Medicine for Osteoarthritis Pain Product and Services
Table 42. Mylan Medicine for Osteoarthritis Pain Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table 44. Daiichi Sankyo Major Business
Table 45. Daiichi Sankyo Medicine for Osteoarthritis Pain Product and Services
Table 46. Daiichi Sankyo Medicine for Osteoarthritis Pain Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. TEVA Basic Information, Manufacturing Base and Competitors
Table 48. TEVA Major Business
Table 49. TEVA Medicine for Osteoarthritis Pain Product and Services
Table 50. TEVA Medicine for Osteoarthritis Pain Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Almatica Pharma Basic Information, Manufacturing Base and Competitors
Table 52. Almatica Pharma Major Business
Table 53. Almatica Pharma Medicine for Osteoarthritis Pain Product and Services
Table 54. Almatica Pharma Medicine for Osteoarthritis Pain Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Astellas Pharma Basic Information, Manufacturing Base and Competitors
Table 56. Astellas Pharma Major Business
Table 57. Astellas Pharma Medicine for Osteoarthritis Pain Product and Services
Table 58. Astellas Pharma Medicine for Osteoarthritis Pain Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Tide Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 60. Tide Pharmaceutical Major Business
Table 61. Tide Pharmaceutical Medicine for Osteoarthritis Pain Product and Services
Table 62. Tide Pharmaceutical Medicine for Osteoarthritis Pain Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Iroko Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 64. Iroko Pharmaceuticals Major Business
Table 65. Iroko Pharmaceuticals Medicine for Osteoarthritis Pain Product and Services
Table 66. Iroko Pharmaceuticals Medicine for Osteoarthritis Pain Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. Hengrui Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 68. Hengrui Pharmaceutical Major Business
Table 69. Hengrui Pharmaceutical Medicine for Osteoarthritis Pain Product and Services
Table 70. Hengrui Pharmaceutical Medicine for Osteoarthritis Pain Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 71. Abiogen Pharma Basic Information, Manufacturing Base and Competitors
Table 72. Abiogen Pharma Major Business
Table 73. Abiogen Pharma Medicine for Osteoarthritis Pain Product and Services
Table 74. Abiogen Pharma Medicine for Osteoarthritis Pain Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 75. Global Medicine for Osteoarthritis Pain Sales by Manufacturer (2019-2021e) & (K Units)
Table 76. Global Medicine for Osteoarthritis Pain Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 77. Market Position of Manufacturers in Medicine for Osteoarthritis Pain, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 78. Global Medicine for Osteoarthritis Pain Production Capacity by Company, (K Units): 2020 VS 2021
Table 79. Head Office and Medicine for Osteoarthritis Pain Production Site of Key Manufacturer
Table 80. Global Medicine for Osteoarthritis Pain Sales by Region (2016-2021e) & (K Units)
Table 81. Global Medicine for Osteoarthritis Pain Sales by Region (2021-2026) & (K Units)
Table 82. Global Medicine for Osteoarthritis Pain Revenue by Region (2016-2021e) & (USD Million)
Table 83. Global Medicine for Osteoarthritis Pain Revenue by Region (2021-2026) & (USD Million)
Table 84. Global Medicine for Osteoarthritis Pain Sales by Type (2016-2021e) & (K Units)
Table 85. Global Medicine for Osteoarthritis Pain Sales by Type (2021-2026) & (K Units)
Table 86. Global Medicine for Osteoarthritis Pain Revenue by Type (2016-2021e) & (USD Million)
Table 87. Global Medicine for Osteoarthritis Pain Revenue by Type (2021-2026) & (USD Million)
Table 88. Global Medicine for Osteoarthritis Pain Price by Type (2016-2021e) & (USD/Unit)
Table 89. Global Medicine for Osteoarthritis Pain Price by Type (2021-2026) & (USD/Unit)
Table 90. Global Medicine for Osteoarthritis Pain Sales by Application (2016-2021e) & (K Units)
Table 91. Global Medicine for Osteoarthritis Pain Sales by Application (2021-2026) & (K Units)
Table 92. Global Medicine for Osteoarthritis Pain Revenue by Application (2016-2021e) & (USD Million)
Table 93. Global Medicine for Osteoarthritis Pain Revenue by Application (2021-2026) & (USD Million)
Table 94. Global Medicine for Osteoarthritis Pain Price by Application (2016-2021e) & (USD/Unit)
Table 95. Global Medicine for Osteoarthritis Pain Price by Application (2021-2026) & (USD/Unit)
Table 96. North America Medicine for Osteoarthritis Pain Sales by Country (2016-2021e) & (K Units)
Table 97. North America Medicine for Osteoarthritis Pain Sales by Country (2021-2026) & (K Units)
Table 98. North America Medicine for Osteoarthritis Pain Revenue by Country (2016-2021e) & (USD Million)
Table 99. North America Medicine for Osteoarthritis Pain Revenue by Country (2021-2026) & (USD Million)
Table 100. North America Medicine for Osteoarthritis Pain Sales by Type (2016-2021e) & (K Units)
Table 101. North America Medicine for Osteoarthritis Pain Sales by Type (2021-2026) & (K Units)
Table 102. North America Medicine for Osteoarthritis Pain Sales by Application (2016-2021e) & (K Units)
Table 103. North America Medicine for Osteoarthritis Pain Sales by Application (2021-2026) & (K Units)
Table 104. Europe Medicine for Osteoarthritis Pain Sales by Country (2016-2021e) & (K Units)
Table 105. Europe Medicine for Osteoarthritis Pain Sales by Country (2021-2026) & (K Units)
Table 106. Europe Medicine for Osteoarthritis Pain Revenue by Country (2016-2021e) & (USD Million)
Table 107. Europe Medicine for Osteoarthritis Pain Revenue by Country (2021-2026) & (USD Million)
Table 108. Europe Medicine for Osteoarthritis Pain Sales by Type (2016-2021e) & (K Units)
Table 109. Europe Medicine for Osteoarthritis Pain Sales by Type (2021-2026) & (K Units)
Table 110. Europe Medicine for Osteoarthritis Pain Sales by Application (2016-2021e) & (K Units)
Table 111. Europe Medicine for Osteoarthritis Pain Sales by Application (2021-2026) & (K Units)
Table 112. Asia-Pacific Medicine for Osteoarthritis Pain Sales by Region (2016-2021e) & (K Units)
Table 113. Asia-Pacific Medicine for Osteoarthritis Pain Sales by Region (2021-2026) & (K Units)
Table 114. Asia-Pacific Medicine for Osteoarthritis Pain Revenue by Region (2016-2021e) & (USD Million)
Table 115. Asia-Pacific Medicine for Osteoarthritis Pain Revenue by Region (2021-2026) & (USD Million)
Table 116. Asia-Pacific Medicine for Osteoarthritis Pain Sales by Type (2016-2021e) & (K Units)
Table 117. Asia-Pacific Medicine for Osteoarthritis Pain Sales by Type (2021-2026) & (K Units)
Table 118. Asia-Pacific Medicine for Osteoarthritis Pain Sales by Application (2016-2021e) & (K Units)
Table 119. Asia-Pacific Medicine for Osteoarthritis Pain Sales by Application (2021-2026) & (K Units)
Table 120. South America Medicine for Osteoarthritis Pain Sales by Country (2016-2021e) & (K Units)
Table 121. South America Medicine for Osteoarthritis Pain Sales by Country (2021-2026) & (K Units)
Table 122. South America Medicine for Osteoarthritis Pain Revenue by Country (2016-2021e) & (USD Million)
Table 123. South America Medicine for Osteoarthritis Pain Revenue by Country (2021-2026) & (USD Million)
Table 124. South America Medicine for Osteoarthritis Pain Sales by Type (2016-2021e) & (K Units)
Table 125. South America Medicine for Osteoarthritis Pain Sales by Type (2021-2026) & (K Units)
Table 126. South America Medicine for Osteoarthritis Pain Sales by Application (2016-2021e) & (K Units)
Table 127. South America Medicine for Osteoarthritis Pain Sales by Application (2021-2026) & (K Units)
Table 128. Middle East & Africa Medicine for Osteoarthritis Pain Sales by Country (2016-2021e) & (K Units)
Table 129. Middle East & Africa Medicine for Osteoarthritis Pain Sales by Country (2021-2026) & (K Units)
Table 130. Middle East & Africa Medicine for Osteoarthritis Pain Revenue by Country (2016-2021e) & (USD Million)
Table 131. Middle East & Africa Medicine for Osteoarthritis Pain Revenue by Country (2021-2026) & (USD Million)
Table 132. Middle East & Africa Medicine for Osteoarthritis Pain Sales by Type (2016-2021e) & (K Units)
Table 133. Middle East & Africa Medicine for Osteoarthritis Pain Sales by Type (2021-2026) & (K Units)
Table 134. Middle East & Africa Medicine for Osteoarthritis Pain Sales by Application (2016-2021e) & (K Units)
Table 135. Middle East & Africa Medicine for Osteoarthritis Pain Sales by Application (2021-2026) & (K Units)
Table 136. Direct Channel Pros & Cons
Table 137. Indirect Channel Pros & Cons
Table 138. Medicine for Osteoarthritis Pain Typical Distributors
Table 139. Medicine for Osteoarthritis Pain Typical Customers
List of Figures
Figure 1. Medicine for Osteoarthritis Pain Picture
Figure 2. Global Medicine for Osteoarthritis Pain Sales Market Share by Type in 2020
Figure 3. Oral
Figure 4. Injection
Figure 5. External
Figure 6. Global Medicine for Osteoarthritis Pain Sales Market Share by Application in 2020
Figure 7. Medical Care
Figure 8. Personal Care
Figure 9. Global Medicine for Osteoarthritis Pain Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 10. Global Medicine for Osteoarthritis Pain Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. United States Medicine for Osteoarthritis Pain Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Canada Medicine for Osteoarthritis Pain Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Mexico Medicine for Osteoarthritis Pain Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Germany Medicine for Osteoarthritis Pain Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. France Medicine for Osteoarthritis Pain Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. United Kingdom Medicine for Osteoarthritis Pain Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Russia Medicine for Osteoarthritis Pain Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Italy Medicine for Osteoarthritis Pain Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. China Medicine for Osteoarthritis Pain Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Japan Medicine for Osteoarthritis Pain Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Korea Medicine for Osteoarthritis Pain Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. India Medicine for Osteoarthritis Pain Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Southeast Asia Medicine for Osteoarthritis Pain Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Australia Medicine for Osteoarthritis Pain Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Brazil Medicine for Osteoarthritis Pain Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Egypt Medicine for Osteoarthritis Pain Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Saudi Arabia Medicine for Osteoarthritis Pain Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. South Africa Medicine for Osteoarthritis Pain Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Turkey Medicine for Osteoarthritis Pain Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Global Medicine for Osteoarthritis Pain Sales (2016-2026) & (K Units)
Figure 31. Global Medicine for Osteoarthritis Pain Production Capacity (2016-2026) & (K Units)
Figure 32. Global Medicine for Osteoarthritis Pain Production Capacity by Geographic Region: 2020 VS 2021
Figure 33. Medicine for Osteoarthritis Pain Market Drivers
Figure 34. Medicine for Osteoarthritis Pain Market Restraints
Figure 35. Medicine for Osteoarthritis Pain Market Trends
Figure 36. Global Medicine for Osteoarthritis Pain Sales Market Share by Manufacturer in 2020
Figure 37. Global Medicine for Osteoarthritis Pain Revenue Market Share by Manufacturer in 2020
Figure 38. Medicine for Osteoarthritis Pain Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 39. Top 3 Medicine for Osteoarthritis Pain Manufacturer (Revenue) Market Share in 2020
Figure 40. Top 6 Medicine for Osteoarthritis Pain Manufacturer (Revenue) Market Share in 2020
Figure 41. Global Medicine for Osteoarthritis Pain Sales Market Share by Region (2016-2026)
Figure 42. Global Medicine for Osteoarthritis Pain Revenue Market Share by Region (2016-2026)
Figure 43. North America Medicine for Osteoarthritis Pain Revenue (2016-2026) & (USD Million)
Figure 44. Europe Medicine for Osteoarthritis Pain Revenue (2016-2026) & (USD Million)
Figure 45. Asia-Pacific Medicine for Osteoarthritis Pain Revenue (2016-2026) & (USD Million)
Figure 46. South America Medicine for Osteoarthritis Pain Revenue (2016-2026) & (USD Million)
Figure 47. Middle East & Africa Medicine for Osteoarthritis Pain Revenue (2016-2026) & (USD Million)
Figure 48. Global Medicine for Osteoarthritis Pain Sales Market Share by Type (2016-2026)
Figure 49. Global Medicine for Osteoarthritis Pain Revenue Market Share by Type (2016-2026)
Figure 50. Global Medicine for Osteoarthritis Pain Price by Type (2016-2026) & (USD/Unit)
Figure 51. Global Medicine for Osteoarthritis Pain Sales Market Share by Application (2016-2026)
Figure 52. Global Medicine for Osteoarthritis Pain Revenue Market Share by Application (2016-2026)
Figure 53. Global Medicine for Osteoarthritis Pain Price by Application (2016-2026) & (USD/Unit)
Figure 54. North America Medicine for Osteoarthritis Pain Sales Market Share by Country (2016-2026)
Figure 55. North America Medicine for Osteoarthritis Pain Revenue Market Share by Country (2016-2026)
Figure 56. North America Medicine for Osteoarthritis Pain Sales Market Share by Type (2016-2026)
Figure 57. North America Medicine for Osteoarthritis Pain Sales Market Share by Application (2016-2026)
Figure 58. Europe Medicine for Osteoarthritis Pain Sales Market Share by Country (2016-2026)
Figure 59. Europe Medicine for Osteoarthritis Pain Revenue Market Share by Country (2016-2026)
Figure 60. Europe Medicine for Osteoarthritis Pain Sales Market Share by Type (2016-2026)
Figure 61. Europe Medicine for Osteoarthritis Pain Sales Market Share by Application (2016-2026)
Figure 62. Asia-Pacific Medicine for Osteoarthritis Pain Sales Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Medicine for Osteoarthritis Pain Revenue Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Medicine for Osteoarthritis Pain Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Medicine for Osteoarthritis Pain Sales Market Share by Application (2016-2026)
Figure 66. South America Medicine for Osteoarthritis Pain Sales Market Share by Country (2016-2026)
Figure 67. South America Medicine for Osteoarthritis Pain Revenue Market Share by Country (2016-2026)
Figure 68. South America Medicine for Osteoarthritis Pain Sales Market Share by Type (2016-2026)
Figure 69. South America Medicine for Osteoarthritis Pain Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Medicine for Osteoarthritis Pain Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Medicine for Osteoarthritis Pain Revenue Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Medicine for Osteoarthritis Pain Sales Market Share by Type (2016-2026)
Figure 73. Middle East & Africa Medicine for Osteoarthritis Pain Sales Market Share by Application (2016-2026)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel
Figure 75. Methodology
Figure 76. Research Process and Data Source
世界の股関節変形性股関節症鎮痛薬市場 2021：企業別、地域別、種類・用途別 The Hip Osteoarthritis Pain Medicine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trad…- 世界の変形性関節症用鎮痛剤市場 2021：企業別、地域別、種類・用途別 The Osteoarthritis Pain Medicine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade re…
- 世界の脊椎変形性関節症鎮痛剤市場 2021：企業別、地域別、種類・用途別 The Spine Osteoarthritis Pain Medicine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tr…
- 世界の変形性関節症鎮痛剤市場規模・現状・予測（2021年-2027年） Drugs for Osteoarthritis Pain market, the main role of osteoarthritis pain drugs is to relieve pain, and cannot slow the progress of osteoarthritis. Geographically, the global Drugs for Osteoarthritis Pain market has been segmented into North America, Europe, China, Japan, Rest of Asia (RoA), and Re…
- 世界の股関節変形性股関節症鎮痛剤市場 2021：企業別、地域別、種類・用途別 The Hip Osteoarthritis Pain Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade re…